3 March 2016 - Is Pharmac’s decision not to prioritise funding melanoma drug Keytruda a case of “putting money before people”, or is it the inevitable outcome of making rational choices with limited resources?

For more details, go to: http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11599505